The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
From Stool Transplants to Next-Generation Microbiota Therapeutics
Open accessAbstract
The epidemic of Clostridium difficile infection fueled by new virulent strains of the organism has led to increased use of fecal microbiota transplantation (FMT). The procedure is effective for even the most desperate cases, after failure of multiple courses of antibiotics. The approach recognizes microbiota to be integral to normal human physiology, and microbiota being used in FMT represents a new class of therapeutics. Imbalance in the composition and altered activity of the microbiota are associated with many diseases. Consequently, there is growing interest in applying FMT to non-C. difficile indications. However, this may succeed only if microbiota therapeutics are developed systematically, based on mechanistic understanding, and applying updo-date principles of microbial ecology. We discuss two pathways in development of this new therapeutic class: whole microbial communities separated from donor stool and an assembly of specific fecal microorganisms grown in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N., Siebert, R., Baron, R. M., Kasper, D. L., et al. (2012) · Science · doi:10.1126/science.1219328 · Cited by 1,661
Antibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380
Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor
Smith, M. I., Yatsunenko, T., Manary, M. J., Trehan, I., Mkakosya, R., Cheng, J., Kau, A. L., Rich, S. S., Concannon, P., Mychaleckyj, J. C., et al. (2013) · Science · doi:10.1126/science.1229000 · Cited by 1,173
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Research works printed but not linked: 68
- Blaser, 2009, What are the consequences of the disappearing human microbiota?, Nat Rev Microbiol, 7, 887, 10.1038/nrmicro2245 · DOI · Paper page
- Schrezenmeir, 2001, Probiotics, prebiotics, and synbiotics–approaching a definition, Am J Clin Nutr, 73, 361S, 10.1093/ajcn/73.2.361s · DOI · Paper page
- de Vrese, 2008, Probiotics, prebiotics, and synbiotics, Adv Biochem Eng Biotechnol, 111, 1
- Sanders, 2008, Probiotics: definition, sources, selection, and uses, Clin Infect Dis, 46, S58, 10.1086/523341 · DOI · Paper page
- Hoffmann, 2013, Science and regulation. Probiotics: finding the right regulatory balance, Science, 342, 314, 10.1126/science.1244656 · DOI
- Borody, 2011, Fecal microbiota transplantation and emerging applications, Nat Rev Gastroenterol Hepatol, 9, 88, 10.1038/nrgastro.2011.244 · DOI · Paper page
- Burke, 2013, Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review, J Am Geriatr Soc, 61, 1394, 10.1111/jgs.12378 · DOI
- Brandt, 2013, An overview of fecal microbiota transplantation: techniques, indications, and outcomes, Gastrointest Endosc, 78, 240, 10.1016/j.gie.2013.03.1329 · DOI · Paper page
- Gough, 2011, Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection, Clin Infect Dis, 53, 994, 10.1093/cid/cir632 · DOI · Paper page
- Ley, 2008, Worlds within worlds: evolution of the vertebrate gut microbiota, Nat Rev Microbiol, 6, 776, 10.1038/nrmicro1978 · DOI · Paper page
- Hopkins, 1998, Application of 13C NMR to investigate the transformations and biodegradation of organic materials by wood- and soil-feeding termites, and a coprophagous litter-dwelling dipteran larva, Biodegradation, 9, 423, 10.1023/A:1008313309557 · DOI
- Guy, 1977, Coprophagy in the African elephant (Loxadonta africana Blumenbach), Afr J Ecol, 15, 174, 10.1111/j.1365-2028.1977.tb00395.x · doi:10.1111/j.1365-2028.1977.tb00395.x
- Payne, 2008, Coprophagy by the semi-habituated chimpanzees of Semliki, Uganda, Pan Africa News, 15, 29, 10.5134/143493 · DOI
- Jasmin, 2011, Perioperative ruminal pH changes in domestic sheep (Ovis aries) housed in a biomedical research setting, J Am Assoc Lab Anim Sci, 50, 27
- McGovern, 2013, Approach to the adult horse with chronic diarrhea, Livestock, 18, 189, 10.12968/live.2013.18.5.189 · doi:10.12968/live.2013.18.5.189
- Nurmi, 1973, New aspects of Salmonella infection in broiler production, Nature, 241, 210, 10.1038/241210a0 · DOI · Paper page
- Zhang, 2012, Should we standardize the 1,700-year-old fecal microbiota transplantation?, Am J Gastroenterol, 107, 1755, 10.1038/ajg.2012.251 · DOI · Paper page
- Lehrer, 2013, Duodenal infusion of feces for recurrent Clostridium difficile, N Engl J Med, 368, 2144
- Eiseman, 1958, Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis, Surgery, 44, 854
- Levine, 2006, Vancomycin: a history, Clin Infect Dis, 42, S5, 10.1086/491709 · DOI · Paper page
- Tvede, 1989, Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients, Lancet, 1, 1156, 10.1016/S0140-6736(89)92749-9 · DOI · Paper page
- Dietrich, 1973, Gnotobiotic care of patients with immunologic deficiency diseases, Transplant Proc, 5, 1271
- van der Waaij, 1977, Reconventionalization following antibiotic decontamination in man and animals, Am J Clin Nutr, 30, 1887, 10.1093/ajcn/30.11.1887 · DOI
- van der Waaij, 1989, The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile, Annu Rev Microbiol, 43, 69, 10.1146/annurev.micro.43.1.69 · doi:10.1146/annurev.micro.43.1.69
- de Vos, 2013, Fame and future of faecal transplantations–developing next-generation therapies with synthetic microbiomes, Microb Biotechnol, 6, 316, 10.1111/1751-7915.12047 · DOI
- Ananthakrishnan, 2011, Clostridium difficile infection: epidemiology, risk factors and management, Nat Rev Gastroenterol Hepatol, 8, 17, 10.1038/nrgastro.2010.190 · DOI · Paper page
- He, 2013, Emergence and global spread of epidemic healthcare-associated Clostridium difficile, Nat Genet, 45, 109, 10.1038/ng.2478 · DOI · Paper page
- Merrigan, 2010, Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production, J Bacteriol, 192, 4904, 10.1128/JB.00445-10 · DOI · Paper page
- Eyre, 2013, Diverse sources of C. difficile infection identified on whole-genome sequencing, N Engl J Med, 369, 1195, 10.1056/NEJMoa1216064 · DOI · Paper page
- Khanna, 2012, The epidemiology of community-acquired Clostridium difficile infection: a population-based study, Am J Gastroenterol, 107, 89, 10.1038/ajg.2011.398 · DOI · Paper page
- Lee, 2013, Community-acquired Clostridium difficile infection: an emerging problem, Curr Emerg Hosp Med Rep, 1, 149, 10.1007/s40138-013-0020-8 · DOI
- Hall, 2012, The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007, Clin Infect Dis, 55, 216, 10.1093/cid/cis386 · DOI · Paper page
- Jarvis, 2009, National point prevalence of Clostridium difficile in US health care facility inpatients, 2008, Am J Infect Control, 37, 263, 10.1016/j.ajic.2009.01.001 · DOI
- Markelov, 2011, Predictors of fatal outcome after colectomy for fulminant Clostridium difficile colitis: a 10-year experience, Am Surg, 77, 977, 10.1177/000313481107700813 · DOI
- Lamontagne, 2007, Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain, Ann Surg, 245, 267, 10.1097/01.sla.0000236628.79550.e5 · DOI · Paper page
- Silverman, 2010, Success of self-administered home fecal transplantation for chronic Clostridium difficile infection, Clin Gastroenterol Hepatol, 8, 471, 10.1016/j.cgh.2010.01.007 · DOI · Paper page
- Bakken, 2011, Treating Clostridium difficile infection with fecal microbiota transplantation, Clin Gastroenterol Hepatol, 9, 1044, 10.1016/j.cgh.2011.08.014 · DOI · Paper page
- Bartlett, 2010, Clostridium difficile: progress and challenges, Ann N Y Acad Sci, 1213, 62, 10.1111/j.1749-6632.2010.05863.x · DOI
- Stevens, 2011, Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection, Clin Infect Dis, 53, 42, 10.1093/cid/cir301 · DOI · Paper page
- Merrigan, 2009, New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration, Int J Antimicrob Agents, 33, S46, 10.1016/S0924-8579(09)70017-2 · DOI
- Banerjee, 2009, Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells, Gut Pathog, 1, 8, 10.1186/1757-4749-1-8 · DOI
- Rea, 2011, Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon, Proc Natl Acad Sci U S A, 108, 4639, 10.1073/pnas.1001224107 · DOI · Paper page
- Wilson, 1983, Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination, J Clin Microbiol, 18, 1017, 10.1128/JCM.18.4.1017-1019.1983 · DOI · Paper page
- Francis, 2013, Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection, PLoS Pathog, 9, e1003356, 10.1371/journal.ppat.1003356 · DOI · Paper page
- Giel, 2010, Metabolism of bile salts in mice influences spore germination in Clostridium difficile, PLoS One, 5, e8740, 10.1371/journal.pone.0008740 · DOI · Paper page
- Kunimoto, 1986, Recurrent Clostridium difficile-associated colitis responding to cholestyramine, Digestion, 33, 225, 10.1159/000199299 · DOI
- Pruksananonda, 1989, Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine, Pediatr Infect Dis J, 8, 175
- Moncino, 1992, Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy, Am J Pediatr Hematol Oncol, 14, 361, 10.1097/00043426-199211000-00015 · DOI
- Jolley, 2000, Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI, Hepatology, 32, 1309, 10.1053/jhep.2000.19811 · DOI
- Pantosti, 1985, Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine, Antimicrob Agents Chemother, 28, 847, 10.1128/AAC.28.6.847 · doi:10.1128/aac.28.6.847
- Cohen, 2010, Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA), Infect Control Hosp Epidemiol, 31, 431, 10.1086/651706 · DOI · Paper page
- Rakoff-Nahoum, 2004, Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis, Cell, 118, 229, 10.1016/j.cell.2004.07.002 · DOI · Paper page
- Jarchum, 2012, Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis, Infect Immun, 80, 2989, 10.1128/IAI.00448-12 · DOI
- Ryan, 2011, A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins, PLoS Pathog, 7, e1002076, 10.1371/journal.ppat.1002076 · DOI · Paper page
- Hung, 2013, Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure, PLoS One, 8, e69577, 10.1371/journal.pone.0069577 · doi:10.1371/journal.pone.0069577
- Jarchum, 2011, Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis, Infect Immun, 79, 1498, 10.1128/IAI.01196-10 · DOI
- Menendez, 2013, Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal Paneth cell alpha-defensins, J Innate Immun, 5, 39
- Giesemann, 2008, Human alpha-defensins inhibit Clostridium difficile toxin B, Gastroenterology, 134, 2049, 10.1053/j.gastro.2008.03.008 · DOI
- Leav, 2010, Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI), Vaccine, 28, 965, 10.1016/j.vaccine.2009.10.144 · DOI · Paper page
- Miller, 2012, Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel, MMWR Surveill Summ, 61, 1
- Starkey, 1989, Markers for transfusion-transmitted disease in different groups of blood donors, JAMA, 262, 3452, 10.1001/jama.1989.03430240088036 · DOI
- Petrof, 2013, Microbial ecosystems therapeutics: a new paradigm in medicine?, Benef Microbes, 4, 53, 10.3920/BM2012.0039 · DOI
- Moore, 1946, Use of sulfasuxidine, streptothricin, and streptomycin in nutritional studies with the chick, J Biol Chem, 165, 437, 10.1016/S0021-9258(17)41154-9 · DOI · Paper page
- Jukes, 1953, Nutritional effects of antibiotics, Pharmacol Rev, 5, 381, 10.1016/S0031-6997(25)07332-6 · DOI
- Haight, 1955, Effect of prolonged antibiotic administration of the weight of healthy young males, J Nutr, 56, 151
- Bennet, 1989, Treatment of ulcerative colitis by implantation of normal colonic flora, Lancet, 1, 164, 10.1016/S0140-6736(89)91183-5 · DOI · Paper page
- Borody, 2003, Treatment of ulcerative colitis using fecal bacteriotherapy, J Clin Gastroenterol, 37, 42, 10.1097/00004836-200307000-00012 · DOI · Paper page
- Kunde, 2013, Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis, J Pediatr Gastroenterol Nutr, 56, 597, 10.1097/MPG.0b013e318292fa0d · DOI · Paper page
Cited by
Probiotics, gut microbiota, and their influence on host health and disease
Sánchez, B., Delgado, S., Blanco‐Míguez, A., Lourenço, A., Gueimonde, M., & Margolles, A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600240 · Cited by 1,104
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 850
Ott, S. J., Waetzig, G. H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J. A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.010 · Cited by 695
Progress in microencapsulation of probiotics: A review
Yao, M., Xie, J., Du, H., McClements, D. J., Xiao, H., & Li, L. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12532 · Cited by 532
Metadata
- Authors
- Petrof, E. O., & Khoruts, A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 146
- Issue
- 6
- Pages
- 1573-1582
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2055281532
- Cited by
- 186
- References
- 27
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From Stool Transplants to Next-Generation Microbiota Therapeutics. https://app.cochat.ai/papers/10.1053/j.gastro.2014.01.004
- The paper
- Petrof, E. O., & Khoruts, A. (2014). From Stool Transplants to Next-Generation Microbiota Therapeutics. Gastroenterology. https://doi.org/10.1053/j.gastro.2014.01.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.